Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

We’re used to hearing that depression is a chemical problem, one that starts in the brain and can only be fixed with ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

About a third of them do not achieve adequate relief from traditional antidepressant medications and psychotherapy. The Pine ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

Neumora Therapeutics ( NMRA) shares crashed 80% to an all-time low Thursday when the biopharmaceutical firm announced that a ...

In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

After six weeks, both the treatment group and the placebo group experienced an average 12.5-point reduction on the Montgomery-Åsberg Depression Rating Scale (MADRS). The drug also fell short in i ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...

How Can Low-Dose Ketamine, a 'Lifesaving' Drug for Major Depression, Alleviate Symptoms Within Hours? Nov. 18, 2024 — Neuroscientists have identified the binding site of low-dose ketamine ...

Depression is a common mental health condition and mood disorder that causes a persistent feeling of sadness and loss of ...